Lorcaserin
| Use attributes for filter ! | |
| Molar mass | 195. 688 g/mol |
|---|---|
| Formula | C11H14ClN |
| Other names | APD-356 |
| Trade name | Belviq |
| Metabolism | Hepatic (extensive) |
| Elimination half-life | 11 hours |
| Music groups | Liraglutide |
| Bupropion / Naltrexone | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951272 |
About Lorcaserin
Lorcaserin, marketed under the brand name Belviq is a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating a type of serotonin receptor known as the 5-HT2C receptor in a region of the brain called the hypothalamus, which is known to control appetite.